EFHC1 Antikörper (Biotin)

Produktnummer ABIN1400335

Produktdetails anti-EFHC1 Antikörper (Biotin)

Target: EFHC1 (EF-Hand Domain (C-terminal) Containing 1 (EFHC1))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser EFHC1 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Kreuzreaktivität: Human, Maus, Ratte

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human EFHC1

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu EFHC1

Target: EFHC1 (EF-Hand Domain (C-terminal) Containing 1 (EFHC1))

Andere Bezeichnung: EFHC1 (EFHC1 Produkte)

Synonyme: MGC63931 antikoerper, zgc:63931 antikoerper, MGC84469 antikoerper, MGC89313 antikoerper, dJ304B14.2 antikoerper, 1700029F22Rik antikoerper, mRib72-1 antikoerper, myoclonin1 antikoerper, EF-hand domain containing 1 antikoerper, EF-hand domain (C-terminal) containing 1 antikoerper, EF-hand domain (C-terminal) containing 1 L homeolog antikoerper, Efhc1 antikoerper, EFHC1 antikoerper, efhc1 antikoerper, efhc1.L antikoerper

Hintergrund:

Synonyms: EF hand domain C terminal containing 1, EF hand domain containing protein 1, EF-hand domain-containing protein 1, Efhc1, EFHC1_HUMAN, EJA1, EJM1, FLJ10466, FLJ37290, JAE, Myoclonin 1, Myoclonin-1.

Background: Defects in EFHC1 are the cause of juvenile myoclonic epilepsy type 1 (EJM1) [MIM:254770]. EJM1 is a subtype of idiopathic generalized epilepsy (IGE). Patients have afebrile seizures only, with onset in adolescence (rather than in childhood) and myoclonic jerks which usually occur after awakening and are triggered by sleep deprivation and fatigue.Genetic variations in EFHC1 are the cause of susceptibility to juvenile absence epilepsy type 1 (JAE1) . JAE is a subtype of idiopathic generalized epilepsy characterized by onset occurring around puberty, absence seizures, generalized tonic-clonic seizures (GTCS), GTCS on awakening, and myoclonic seizures.

Gen-ID: 114327